In the case of GDM, since these women are likely to undergo blood tests for various reasons, our results suggest that early measurement of ALT may help to identify women at high risk of GDM, especially in the presence of obesity/overweight. This evidence concerns the gene GPT and obesity due to melanocortin 4 receptor deficiency.